The FDA has approved an update to the prescribing information for Merck‘s PAH treatment Winrevair (sotatercept-csrk).

PAH has increased worldwide in older adults, largely due to growing aging populations, with the greatest risk factors in ...

Pulmonary hypertension treatment can help slow disease progression, ease symptoms, and improve quality of life for people with the disease.

Time is a precious commodity, says columnist Jolie Lizana, who spends too many hours each month managing her health with PH.

Treatment with anticoagulants, also known as blood thinners, does not extend survival in people with pulmonary arterial hypertension (PAH), according to a large French study. These findings were ...